Advertisement

The administration of antibiotics to animals to prevent or treat diseases led us to be concerned about the impact of these antibiotics on human health. In fact, animal products could be a potential vehicle to transfer drugs to humans. Using appropri ated mathematical and statistical models, one can predict the kinetic profile of drugs and their metabolites and, consequently, develop preventive procedures regarding drug transmission (i.e., determination of appropriate withdrawal periods). Nevertheless, in the present chapter the mathematical and statistical concepts for data interpretation are strictly given to allow understanding of some basic pharma-cokinetic principles and to illustrate the determination of withdrawal periods

Keywords

Animal Product Clinical Pharmacokinetic Elimination Rate Constant Maximum Residue Limit Veterinary Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anadón A (1990). Les residues de substances chimiques dans les aliments d'origine animale en Espagne. B. Acad. Vet. France. 63: 245 –252Google Scholar
  2. Anadón A; Martínez-Larra ñaga MR (1992). Pharmacology and toxicology of quinolones. In: Sunshine, I. (ed). Recent Developments in Therapeutic Drug Monitoring and Clinical Toxicology, Marcel Dekker, New York, pp. 193 –198Google Scholar
  3. Anadón A; Martínez-Larra ñaga MR (1999). Residues of antimicrobial drugs and feed additives in animal products: regulatory aspects. Livestock Production Science 59: 183 –189CrossRefGoogle Scholar
  4. Anon (1996). Committee for Veterinary Medicinal Products. Note for Guidance: Approach Towards Harmonisation of Withdrawal Periods. (EMEA/CVMP/036/95/FINAL)Google Scholar
  5. Anon (2000). Committee for Veterinary Medicinal Products (2000). Note for Guidance for the Determination of Withdrawal Periods for Milk. (EMEA/CVMP/473/98/FINAL)Google Scholar
  6. Anon (2001). Committee for Veterinary Medicinal Products (2001). Note for Guidance on the Risk Analysis Approach for Residues of Veterinary Medicinal Products in Food of Animal Origin. (EMEA/CVMP/187/00/FINAL)Google Scholar
  7. Anon (2003). Committee for Veterinary Medicinal Products (2003). Guideline on Pre-Authorisation Studies to Assess the Potential for Resistance Resulting from the Use of Antimicrobial Veterinary Medicinal Products. (EMEA/CVMP/244/01/FINAL)Google Scholar
  8. Anon (2004). National Office of Animal Health. (2004). Antibiotics for Animals: An Overview. Briefing Document No. 6Google Scholar
  9. Birkett DJ (1998). Pharmacokinetics Made Easy, McGraw-Hill, AustraliaGoogle Scholar
  10. Chester T; Deluyker H; Aerts R; Koopman P, Davot JL (1996). Further considerations in setting milk withholding times for antimicrobials. In: Haagsma N; Ruiter A (eds). Residues of Veterinary Drugs in Food. Proceedings of the Eu-roresidue III Conference, Veldhoven, 6 –8 May, pp. 326 –330Google Scholar
  11. European Commission (2003). Notice to Applicants and Note for Guidance: Establishment of Maximum Residue Limits (MRLs) for Residues of Veterinary Medicinal Products in Foodstuffs of Animal OriginGoogle Scholar
  12. FDA (1994). General Principles for Evaluating the Safety of Compounds Used in Food-Producing AnimalsGoogle Scholar
  13. Gabrielsson J; Weiner D (2000). Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts &Applications, 3rd edn. Swedish Pharmaceutical Press, Stockholm, SwedenGoogle Scholar
  14. Jones PGH (1997). Regulatory harmonization for veterinary medicines in the European Union. In: Anadón, A.; McKellar, Q. (eds.). Proceedings of the 7th EAVPT International Congress,Madrid (Spain), 6 –7 July. J. Vet. Pharmacol. Ther. 20(Suppl. 1): 1 –9Google Scholar
  15. Roland M; Tozer TN (1995). Clinical Pharmacokinetics: Concepts and Applications, 3rd edn. Lippincott Williams &Wilkins, USAGoogle Scholar
  16. Shargel L; Yu ABC (1999). Applied Biopharmaceutics &Pharmacokinetics, 4th edn. McGraw-Hill, NY, USAGoogle Scholar
  17. Stang K (1971). Angewandte Statistik, Springer, Berlin. Vol. II, pp. 141 –143Google Scholar
  18. Vanic ML; Marangunich L; Fern ández Courel H; Fern ández Su árez A (2003). Estimation the withdrawal period for veterinary drugs used in food producing animals. Anal. Chim. Acta. 483: 251 –257CrossRefGoogle Scholar
  19. WHO. (1989). Gudelines for Predicting Dietary Intake of Pesticide Residues. GenevaGoogle Scholar
  20. WHO. (1997). The Medical Impact of the Use of Antimicrobial in for Animals. Berlin (Germany), 13 –17 October. (Report of WHO Meeting)Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Amílcar C. Falcão
    • 1
  1. 1.Faculty of PharmacyUniversity of CoimbraCoimbraPortugal

Personalised recommendations